Open AccessTotal-tau in cerebrospinal fluid of patients with multiple sclerosis decreases in secondary progressive stage of disease and reflects degree of brain atrophy
Author(s) -
Jacek Jaworski,
Marek Psujek,
Marzena Janczarek,
Małgorzata Szczerbo-Trojanowska,
Halina Bartosik-Psujek
Publication year - 2012
Publication title -
upsala journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.808
H-Index - 41
eISSN - 2000-1967
pISSN - 0300-9734
DOI - 10.3109/03009734.2012.669423
Subject(s) - multiple sclerosis , medicine , cerebrospinal fluid , atrophy , expanded disability status scale , pathology , magnetic resonance imaging , population , parenchyma , gastroenterology , immunology , radiology , environmental health
Tau protein is a potential marker of neuronal damage. The aim of the study is to investigate its potential role as a marker of brain atrophy in multiple sclerosis (MS).